These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11859144)

  • 1. The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
    Zhang GX; Xu H; Kishi M; Calida D; Rostami A
    J Immunol; 2002 Mar; 168(5):2501-7. PubMed ID: 11859144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase.
    Weishaupt A; Jander S; Brück W; Kuhlmann T; Stienekemeier M; Hartung T; Toyka KV; Stoll G; Gold R
    J Immunol; 2000 Dec; 165(12):7157-63. PubMed ID: 11120847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.
    Xiao BG; Huang YM; Yang JS; Xu LY; Link H
    Clin Exp Immunol; 2001 Aug; 125(2):300-9. PubMed ID: 11529923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.
    Burkhart C; Liu GY; Anderton SM; Metzler B; Wraith DC
    Int Immunol; 1999 Oct; 11(10):1625-34. PubMed ID: 10508180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis.
    Deng C; Minguela A; Hussain RZ; Lovett-Racke AE; Radu C; Ward ES; Racke MK
    J Immunol; 2002 May; 168(9):4511-8. PubMed ID: 11970996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.
    Lenz DC; Wolf NA; Swanborg RH
    J Immunol; 1999 Aug; 163(4):1763-8. PubMed ID: 10438907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
    Hofstetter HH; Shive CL; Forsthuber TG
    J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
    Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
    J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
    Faunce DE; Terajewicz A; Stein-Streilein J
    J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
    Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
    Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes.
    Mekala DJ; Alli RS; Geiger TL
    J Immunol; 2005 Mar; 174(6):3789-97. PubMed ID: 15749920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.